Dermata Therapeutics, Inc. (DRMA) stock
DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.62−0.04 (-6.01%)
Close on Nov 13, 2026Market cap $2.50MP/E –Yield –
Dermata Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Dermata Therapeutics's total assets was $6.64M at Sep 30, 2026. For fiscal 2025 it was $7.86M, up 122.5% from the year before. The highest annual figure on record is $11.62M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.86M | +122.5% |
| FY2024 | Dec 31, 2024 | $3.53M | -55.7% |
| FY2023 | Dec 31, 2023 | $7.98M | +14.9% |
| FY2022 | Dec 31, 2022 | $6.94M | -40.3% |
| FY2021 | Dec 31, 2021 | $11.62M | +1819.9% |
| FY2020 | Dec 31, 2020 | $605.45K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.64M | +30.8% |
| Q2 FY2026 | Jun 30, 2026 | $5.32M | -19.9% |
| Q1 FY2026 | Mar 31, 2026 | $7.47M | -25.4% |
| Q4 FY2025 | Dec 31, 2025 | $7.86M | +122.5% |
| Q3 FY2025 | Sep 30, 2025 | $5.07M | -24.2% |
| Q2 FY2025 | Jun 30, 2025 | $6.64M | +26.8% |
| Q1 FY2025 | Mar 31, 2025 | $10.01M | +93.2% |
| Q4 FY2024 | Dec 31, 2024 | $3.53M | -55.7% |
| Q3 FY2024 | Sep 30, 2024 | $6.69M | -8.7% |
| Q2 FY2024 | Jun 30, 2024 | $5.24M | -39.9% |
| Q1 FY2024 | Mar 31, 2024 | $5.18M | -44.3% |
| Q4 FY2023 | Dec 31, 2023 | $7.98M | +14.9% |
| Q3 FY2023 | Sep 30, 2023 | $7.32M | -18.4% |
| Q2 FY2023 | Jun 30, 2023 | $8.71M | -21.0% |
| Q1 FY2023 | Mar 31, 2023 | $9.30M | +2.8% |
| Q4 FY2022 | Dec 31, 2022 | $6.94M | -40.3% |
| Q3 FY2022 | Sep 30, 2022 | $8.97M | -34.4% |
| Q2 FY2022 | Jun 30, 2022 | $11.03M | +869.9% |
| Q1 FY2022 | Mar 31, 2022 | $9.04M | +1393.8% |
| Q4 FY2021 | Dec 31, 2021 | $11.62M | – |
| Q3 FY2021 | Sep 30, 2021 | $13.69M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.14M | – |
| Q4 FY2020 | Dec 31, 2020 | $605.45K | – |
See a number that looks wrong?